Tirzepatide as Compared with Semaglutide for the Treatment of Type 2 Diabetes
Unwanted effects could be mild to severe, depending on the dosage
Jayaraj VJ, Chong DW-Q, Wan K-S, et al
Staff TAP: New Findings Suggest No Correlation Between GLP1 Receptor Agonists and Thyroid Cancer Risk, The ASCO Post, 2024
Discovery Call Free consultation Biomarker Test 80+ markers Team Review Full analysis Consultation 60 minutes Ongoing Support Continuous care Free Discovery Call Talk with our patient coordinator about your goals, symptoms, and concerns Understand your options and what to expect Get matched with the right provider for your needs Result: A clear next step personalized to your situation, with no pressure or commitment
K.GoK.CliffordT.et al (2023b)